Blockade of TSLP pathway alters asthma biomarkers
J. Bigler, M. Boedigheimer, K. Gorski, P. O'Byrne, Y. Wang, G. Gauvreau, L. P. Boulet, D. Cockcroft, M. FitzGerald, B. Davis, C. Dias, L. Smith, E. Bautista, R. Leigh, A. Welcher, J. Parnes (Seattle, Thousand Oaks, United States Of America; Hamilton, Laval, Saskatoon, Vancouver, Calgary, Canada)
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Session: Clinical trials of drugs for respiratory diseases
Session type: Oral Presentation
Number: 4672
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Bigler, M. Boedigheimer, K. Gorski, P. O'Byrne, Y. Wang, G. Gauvreau, L. P. Boulet, D. Cockcroft, M. FitzGerald, B. Davis, C. Dias, L. Smith, E. Bautista, R. Leigh, A. Welcher, J. Parnes (Seattle, Thousand Oaks, United States Of America; Hamilton, Laval, Saskatoon, Vancouver, Calgary, Canada). Blockade of TSLP pathway alters asthma biomarkers. Eur Respir J 2014; 44: Suppl. 58, 4672
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: